Ingenza, in partnership with the University of Dundee and Drochaid Research Services, will work on a project to recycle CO2 emissions from bioprocessing plants to serve as feedstock and energy inputs.
Ingenza, a UK-based provider of bioprocessing services, announced on May 31, 2018, that it has entered into a collaboration with the University of Dundee and Drochaid Research Services on a project that aims to reduce the waste carbon dioxide (CO2) generated by industrial biotech manufacturing applications.
The proposal, which is funded by Zero Waste Scotland, involves capturing and recycling emerging CO2 waste streams that evolve during fermentative bioprocessing and using them as a supplementary carbon feedstock for bio-based chemical manufacturing. This is expected to create “circularized”sustainable feedstock and energy inputs required for bio-based manufacturing.
The project funding includes £18 million (US$24 million) from the Circular Economy Investment Fund, which supports work that will deliver circular economy growth in line with Scottish Government objectives and targets. The Circular Economy Investment Fund is supported by the Scottish Government and the European Regional Development Fund through the £73 million (US$97 million) Resource Efficiency Circular Economy Accelerator Programme.
“This is a really exciting venture for Ingenza and reflects our commitment to sustainable solutions. The project will allow us to apply our expertise and resources to this important aspect of industrial biomanufacturing, as we seek to develop novel approaches to help reduce waste CO2,” said Ian Fotheringham, managing director of Ingenza, in a company press release.
“We’re delighted to support this new project from Scottish firm Ingenza and its partners, which is exactly the kind of innovative business initiative that the Circular Economy Investment Fund was set up to support. The bioeconomy is a key sector in the development of a more circular economy in Scotland, with tremendous opportunities for turning existing waste and by-products from industrial processes into new business opportunities,” added Iain Gulland, chief executive, Zero Waste Scotland, in the press release.
Source: Ingenza
EMA Recommends Imfinzi-Based Perioperative Regimen for Treating Resectable NSCLC
March 10th 2025The committee’s recommendation is based on results from a Phase III trial in which Imfinzi demonstrated a reduced risk of recurrence, progression, or death by 32% compared to neoadjuvant chemotherapy alone.
International Women’s Day 2025: A Promising Future for Gender Diversity in Pharma
March 8th 2025In an interview with BioPharm International®, Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.